Cargando…
Therapeutic potential of exosome‐based personalized delivery platform in chronic inflammatory diseases
In the inflammatory microenvironment, there are numerous exosomes secreted by immune cells (Macrophages, neutrophils, dendritic cells), mesenchymal stem cells (MSCs) and platelets as intercellular communicators, which participate in the regulation of inflammation by modulating gene expression and re...
Autores principales: | Wang, Chenglong, Xu, Maochang, Fan, Qingze, Li, Chunhong, Zhou, Xiangyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989662/ https://www.ncbi.nlm.nih.gov/pubmed/36896446 http://dx.doi.org/10.1016/j.ajps.2022.100772 |
Ejemplares similares
-
Utilizing Exosomal-EPHs/Ephrins as Biomarkers and as a Potential Platform for Targeted Delivery of Therapeutic Exosomes
por: Goutas, Dimitrios, et al.
Publicado: (2022) -
Oral hydrogel nanoemulsion co-delivery system treats inflammatory bowel disease via anti-inflammatory and promoting intestinal mucosa repair
por: Lei, Fenting, et al.
Publicado: (2023) -
Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome
por: Lai, Ruenn Chai, et al.
Publicado: (2012) -
Plant-derived exosomal nanoparticles: potential therapeutic for inflammatory bowel disease
por: Li, De-feng, et al.
Publicado: (2023) -
Exosomes and mimics as novel delivery platform for cancer therapy
por: Yang, Fuxu, et al.
Publicado: (2022)